Corneal Cross-linking for Progressive Keratoconus: Up to 13 Years of Follow-up

圆锥角膜 眼科 视力 角膜地形图 医学 角膜胶原交联 人口 角膜 环境卫生
作者
Riccardo Vinciguerra,Luca Pagano,Alfredo Borgia,Alessio Montericcio,Emanuela F. Legrottaglie,Raffaele Piscopo,Pietro Rosetta,Paolo Vinciguerra
出处
期刊:Journal of Refractive Surgery [Slack Incorporated (United States)]
卷期号:36 (12): 838-843 被引量:62
标识
DOI:10.3928/1081597x-20201021-01
摘要

PURPOSE: To assess the long-term efficacy and safety of epithelium-off corneal cross-linking according to the Dresden protocol (S-CXL) in progressive keratoconus. METHODS: Patients treated with S-CXL from April 2006 to January 2010 at Humanitas Clinical and Research Center, Rozzano, Italy, who completed at least 10 years of follow-up were included. Corrected distance visual acuity (CDVA), refraction, and corneal topography and tomography with Pentacam (OCULUS Optikgeräte GmbH) were evaluated at baseline and 10+ years after the procedure. The definition of progression after S-CXL was two of the following three criteria: increase of “A” value, increase of “B” value, or decrease of minimum thickness evaluated with the ABCD progression display above 95% CI for the post-CXL population. RESULTS: Twenty-seven eyes of 22 patients were included. At a mean of 11 years of follow-up (maximum 13 years), S-CXL was able to maintain CDVA and induce significant regularization of the corneal surface as demonstrated by a significant decrease of the central keratoconus index ( P = .035) and a decrease of anterior curvature (“A” value) starting from 2.54 ± 2.46, which reduced to 1.14 ± 1.60 ( P = .005) at 10+ years of follow-up. Two of 27 eyes included showed significant progression after S-CXL (7.4%). CONCLUSIONS: S-CXL was confirmed to be a safe and effective treatment for progressive keratoconus with a failure rate of 7.4% at up to 13 years of follow-up. The authors suggest the use of a combined progression system that evaluates anterior and posterior curvature and with thickness map together with the knowledge of the noise level of the testing system. [ J Refract Surg . 2020;36(12):838–843.]
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xie完成签到,获得积分10
1秒前
桦奕兮完成签到 ,获得积分10
1秒前
craccola发布了新的文献求助10
1秒前
852应助Yule采纳,获得10
2秒前
青青儿完成签到,获得积分10
3秒前
97_完成签到,获得积分10
4秒前
量子星尘发布了新的文献求助10
5秒前
搜集达人应助彭梁_come_on采纳,获得10
5秒前
了然完成签到,获得积分10
5秒前
wanci应助小嚣张采纳,获得10
5秒前
6秒前
顾矜应助liqianniu采纳,获得10
7秒前
青山完成签到 ,获得积分10
8秒前
田园发布了新的文献求助10
10秒前
传奇3应助羽木采纳,获得10
10秒前
高高绮玉应助浮浮世世采纳,获得10
11秒前
11秒前
15秒前
烂漫的从彤完成签到,获得积分10
16秒前
16秒前
16秒前
JamesPei应助帅气的馒头采纳,获得10
16秒前
17秒前
Miao完成签到,获得积分10
18秒前
princeyxx发布了新的文献求助10
18秒前
天天快乐应助inn采纳,获得10
18秒前
19秒前
乐乐应助肖鹏采纳,获得10
19秒前
爱听歌的大地完成签到,获得积分10
19秒前
19秒前
19秒前
Evak发布了新的文献求助10
20秒前
6466完成签到,获得积分10
21秒前
光合作用完成签到,获得积分10
22秒前
22秒前
22秒前
22秒前
羽木完成签到,获得积分10
22秒前
Yule发布了新的文献求助10
23秒前
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Contemporary Debates in Epistemology (3rd Edition) 1000
International Arbitration Law and Practice 1000
文献PREDICTION EQUATIONS FOR SHIPS' TURNING CIRCLES或期刊Transactions of the North East Coast Institution of Engineers and Shipbuilders第95卷 1000
BRITTLE FRACTURE IN WELDED SHIPS 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6160455
求助须知:如何正确求助?哪些是违规求助? 7988740
关于积分的说明 16605765
捐赠科研通 5268668
什么是DOI,文献DOI怎么找? 2811172
邀请新用户注册赠送积分活动 1791287
关于科研通互助平台的介绍 1658143